Hemlibra 105mg Injection contains the active constituent Emicizumab. It belongs to the class of medications called monoclonal antibodies. It is used to treat patients with haemophilia A who have developed factor VIII inhibitors. It is also indicated to treat severe haemophilia A patients who have not developed factor VIII inhibitors (the FVIII blood level is less than 1%).

Haemophilia A is an inherited condition caused by a lack of factor VIII, an essential substance required for blood to clot and stop bleeding. Monoclonal antibodies are a type of protein that recognize and bind to a target in the body. The medicine prevents bleeding or reduces bleeding episodes in people with this condition.

Do not take Hemlibra 105mg Injection if you are allergic to Emicizumab or any other ingredients. Before you start using this medicine, it is very important to talk to your doctor about using any other medications. Inform your physician immediately if bleeding occurs after taking this medicine. This medicine is used in all age groups. Do not give this injection where the skin is red, bruised, tender, hard, or in areas where there are moles or scars.

Very secure payment methods
Shipping will be calculated on checkout
Please note that price may increase due to exchange rate, ensure updated price before making payment